Opportunity Information: Apply for RFA AG 21 010

The National Institutes of Health (NIH) funding opportunity titled "Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed)" (Funding Opportunity Number RFA-AG-21-010; CFDA 93.866) supports basic and mechanistic research focused on how glial cells change during aging and how those changes shape brain health over time. The central idea behind the announcement is that glia are not uniform cell populations; instead, they show major spatial and temporal diversity, meaning that glial cells of the same broad type can differ depending on where they are in the brain, when they are observed, and what conditions the brain is experiencing. The opportunity emphasizes that this within-cell-type heterogeneity appears to evolve as organisms age, potentially giving rise to distinct glial subpopulations with different physiological roles. NIH is seeking projects that fill key knowledge gaps about whether, how, and why these emerging glial subtypes contribute either to vulnerability (increased risk of decline, dysfunction, or pathology) or resilience (maintenance of function and protection against age-related stressors) in the aging brain.

This is an R01 research project grant mechanism, which generally indicates support for well-developed, hypothesis-driven studies that can deliver clear, publishable advances in understanding. The "Clinical Trial Not Allowed" designation signals that applications should not propose clinical trials; the intent is to fund preclinical, foundational, or other non-trial human research that advances biological understanding rather than testing an intervention in a clinical trial framework. In practice, competitive projects for a topic like this commonly center on identifying and characterizing glial subpopulations, mapping their distribution across brain regions and across the lifespan, determining how aging reshapes their gene expression and functional properties, and clarifying how these changes influence neuronal circuits and overall brain function. The announcement is framed around "glial plasticity," so studies that illuminate how glia adapt, transition between states, or shift roles during aging are especially aligned, particularly when those state changes can be tied to mechanisms that might explain resilience versus susceptibility to age-related cognitive or neurological decline.

The eligibility criteria are broad and include many organization types across the public, private, nonprofit, and academic sectors. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations other than small businesses; small businesses; and additional categories captured under "others." The announcement also highlights a wide range of "other eligible applicants," underscoring an inclusive posture toward institutions and organizations that serve specific communities or operate in unique jurisdictions. These include Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible agencies of the federal government; regional organizations; U.S. territories or possessions; Indian/Native American tribal governments that are not federally recognized; and non-domestic (non-U.S.) entities, meaning foreign organizations can apply.

Key administrative details provided in the source data include an original closing date of 2020-06-17 and a creation date of 2019-12-17. The award ceiling listed is $250,000, indicating the upper limit specified in the opportunity materials for budget considerations as presented in the dataset. The opportunity category is discretionary, the funding instrument type is a grant, and the activity category is health, consistent with NIH biomedical research support. Overall, the opportunity is aimed at accelerating a more precise, subtype-level understanding of glial biology in aging, with the expectation that clarifying which glial subpopulations drive harmful versus protective aging trajectories will sharpen the field's ability to explain brain aging and identify future therapeutic directions, even though this particular announcement does not support clinical trials.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2019-12-17.
  • Applicants must submit their applications by 2020-06-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $250,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 21 010

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)

Previous opportunity: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 21 010

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 21 010) also looked into and applied for these:

Funding Opportunity
Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed) Apply for RFA AG 21 002

Funding Number: RFA AG 21 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 072

Funding Number: RFA AI 19 072
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 20 078

Funding Number: PAR 20 078
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 008

Funding Number: RFA RM 20 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 007

Funding Number: RFA RM 20 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Surgical Disparities Research (R01 - Clinical Trial Optional) Apply for PAR 20 079

Funding Number: PAR 20 079
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Apply for PAR 20 084

Funding Number: PAR 20 084
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 20 037

Funding Number: PAR 20 037
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) Apply for RFA OD 20 002

Funding Number: RFA OD 20 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) Apply for PAR 20 038

Funding Number: PAR 20 038
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
MoTrPAc Phase 2 Animal Studies (U01 Clinical Trial Not Allowed) Apply for RFA RM 20 009

Funding Number: RFA RM 20 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Infrastructure for the Expansion of Rhesus macaque Colonies to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) Apply for PAR 20 087

Funding Number: PAR 20 087
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 20 086

Funding Number: PAR 20 086
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mendelian Genomics Research Centers (U01 Clinical Trial Optional) Apply for RFA HG 20 007

Funding Number: RFA HG 20 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional) Apply for RFA AG 21 011

Funding Number: RFA AG 21 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Mendelian Genomics Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HG 20 008

Funding Number: RFA HG 20 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed Apply for PAR 20 090

Funding Number: PAR 20 090
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed) Apply for PAR 20 095

Funding Number: PAR 20 095
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) Apply for PAR 20 093

Funding Number: PAR 20 093
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) Apply for PAR 20 080

Funding Number: PAR 20 080
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 21 010", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: